Publicaciones en las que colabora con P. Coto-Segura (49)

2017

  1. Sentinel lymph node biopsy plus wide local excision vs. wide location excision alone for primary cutaneous melanoma: a systematic review and meta-analysis

    Journal of the European Academy of Dermatology and Venereology, Vol. 31, Núm. 2, pp. 241-246

2015

  1. Association between single nucleotide polymorphisms IL17RA rs4819554 and IL17E rs79877597 and Psoriasis in a Spanish cohort

    Journal of Dermatological Science, Vol. 80, Núm. 2, pp. 111-115

  2. CDKAL1 gene variants affect the anti-TNF response among Psoriasis patients

    International Immunopharmacology, Vol. 29, Núm. 2, pp. 947-949

  3. Cutaneous spread of primary neuroendocrine breast carcinoma with apocrine differentiation

    Journal of the European Academy of Dermatology and Venereology

  4. Efficacy of adalimumab in the treatment of moderate-to-severe psoriasis: A retrospective study of 100 patients in daily practice

    Journal of Dermatological Treatment, Vol. 26, Núm. 1, pp. 49-53

  5. Merkel cell carcinoma and Merkel cell polyomavirus: A systematic review and meta-analysis

    British Journal of Dermatology, Vol. 173, Núm. 1, pp. 42-49

  6. Psoriasis vulgaris with or without arthritis and independent of disease severity or duration is a risk factor for hypercholesterolemia

    Dermatology, Vol. 230, Núm. 2, pp. 170-176

  7. The Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patients

    Pharmacogenetics and Genomics, Vol. 25, Núm. 6, pp. 313-316

  8. The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients

    Archives of Dermatological Research, Vol. 307, Núm. 5, pp. 405-412

2014

  1. Effect of the FTO rs9930506 polymorphism on obesity and the main clinical outcomes in patients with psoriasis

    British Journal of Dermatology

  2. Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus

    Journal of Dermatological Science, Vol. 75, Núm. 3, pp. 167-172

2013

  1. Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: A systematic review and meta-analysis

    British Journal of Dermatology, Vol. 169, Núm. 4, pp. 783-793

  2. SNP rs11652075 in the CARD14 gene as a risk factor for psoriasis (PSORS2) in a Spanish Cohort

    DNA and Cell Biology, Vol. 32, Núm. 10, pp. 601-604

2012

  1. Actitud ante un paciente con cara roja aguda

    Dermatología en urgencias: guía práctica (Editorial Médica Panamericana), pp. 54-60

  2. Common European mitochondrial haplogroups in the risk for psoriasis and psoriatic arthritis

    Genetic Testing and Molecular Biomarkers, Vol. 16, Núm. 6, pp. 621-623

  3. Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitor

    Australasian Journal of Dermatology, Vol. 53, Núm. 1, pp. 70-72

  4. Psoriasis and hypertension: A case-control study

    Journal of the European Academy of Dermatology and Venereology, Vol. 26, Núm. 6, pp. 785-788

  5. Psoriasis and type 2 diabetes risk among psoriatic patients in a Spanish population

    Australasian Journal of Dermatology, Vol. 53, Núm. 2, pp. 128-130

  6. Resequencing of the IL12B gene in psoriasis patients with the rs6887695/rs3212227 risk genotypes

    Cytokine, Vol. 60, Núm. 1, pp. 27-29

2011

  1. Acute renal failure caused by imiquimod 5% cream in a renal transplant patient: Review of the literature on side effects of imiquimod

    Dermatology, Vol. 222, Núm. 2, pp. 109-112